معرفی
Dr Chris Jones serves as Principal Research Fellow in Medical Statistics at Brighton and Sussex Medical School (BSMS), a partnership between the University of Brighton and University of Sussex. Based at the University of Brighton's Watson Building, he collaborates extensively with the Brighton and Sussex Clinical Trials Unit and external healthcare organizations. His work integrates statistical methodology with clinical and laboratory research across diverse medical domains.
His educational background includes:
- BSc in Biochemistry (2007)
- PhD in Molecular Biology and Genetics from BSMS (2011)
- BA in Mathematics and Statistics from Open University (2017)
Dr Jones' research centers on biostatistics for clinical trials and genomic analysis, with particular expertise in RNA-seq data interpretation and experimental design for molecular biology studies. His methodology bridges quantitative analysis and wet-lab validation, addressing challenges in cancer biology, mental health interventions, and infectious disease. Recent work demonstrates increasing focus on digital health pathways and pragmatic trial designs within NHS frameworks.
His publication portfolio (2021-2024) reveals strong interdisciplinary trends, with clinical trials dominating mental health and oncology applications while maintaining foundational work in RNA biology. Key journals include The Lancet Regional Health - Europe and British Journal of Cancer, indicating significant impact in translational medicine.
Professional recognitions include:
- Chartered Statistician (Royal Statistical Society, 2019)
- Chartered Scientist (Royal Society of Biology, 2019)
Dr Jones has secured funding through BBSRC, Brighton University Rising Stars Initiative, and Sussex Research Development Fund for past projects. Current activities involve multiple clinical trials coordinated through BSMS, with emphasis on implementation science and cost-effectiveness analysis. He maintains active collaborations across UK healthcare systems but does not lead a named research laboratory.
Though no dedicated lab is documented, his dual expertise enables unique integration of statistical analysis with molecular biology techniques. Prospective collaborators would engage with his clinical trials unit affiliations and methodological strengths in genomic data analysis and trial design.
